Obesity In India
- All
- News
- Videos
- Web Stories
-
New Experimental Obesity Drugs Target Mitochondria To Burn More Calories: Australian Study
The team, led by researchers from the University of Technology Sydney in Australia, focussed on "mitochondrial uncouplers" - molecules that make cells burn energy less efficiently and release fuel as heat instead of converting it into energy the body
-
Did UP Teen Die Of Excess Junk Food? Doctors Debunk Claims
An 11th standard student from Uttar Pradesh died at Delhi AIIMS due to multiple illnesses, including severe typhoid complications, TB and cardiac arrest, doctors said.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
Cancer History In Family? What You Can Do To Reduce Risk
When multiple members of a family have had cancer especially at young ages or at the same site, it can signal inherited risk factors.
-
2026 Needs A National Obesity Strategy: Doctor Explains Why Weight Is Now A Public Health Emergency
The rising obesity trend is seriously worrying and requires urgent, dedicated and consistent intervention on both micro and macro scales.
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Doctor Shares The Top Healthcare Challenges India Must Solve In 2026, Before The Costs Become Unmanageable
Dr Sabine Kapasi explains how India is entering a year where further delay in healthcare reforms and advances will widen existing gaps in care.
-
Ozempic, Type 2 Diabetes, Weight Loss Drug Launched In India. Check Price
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming diabetes and obesity market expected to power industry growth this decade.
-
Study Finds Low Blood Choline As Possible Factor In Obesity-Related Alzheimer's Risk
A study links low blood choline levels in obese young adults to liver dysfunction, insulin resistance, and markers associated with increased Alzheimer's risk.
-
One In Four Indian Adults Obese, Claims New Report
Quoting the National Family Health Survey 2019-21, the study says that in Delhi, 41 per cent of women are obese compared to 12 per cent in Meghalaya.
-
Ultra-Processed Food Sales Surge In India, Causing Obesity And Diabetes Crisis: Lancet Study
India is seeing the fastest ultra-processed food (UPF) sales growth, which is surging obesity and diabetes cases, according to The Lancet.
-
"Reduce Edible Oil Consumption By 10 Per Cent": PM Narendra Modi's Message During Chat With Women's World Cup Winners
PM Narendra Modi advised people to reduce their consumption of edible oil at home as part of a larger national health initiative.
-
Opinion | The Rich Get Fit, And Poor Get 'Lectures' - That's India's Ozempic Problem
Ozempic has arrived in India - and so has the moral panic around it.
-
New Experimental Obesity Drugs Target Mitochondria To Burn More Calories: Australian Study
The team, led by researchers from the University of Technology Sydney in Australia, focussed on "mitochondrial uncouplers" - molecules that make cells burn energy less efficiently and release fuel as heat instead of converting it into energy the body
-
Did UP Teen Die Of Excess Junk Food? Doctors Debunk Claims
An 11th standard student from Uttar Pradesh died at Delhi AIIMS due to multiple illnesses, including severe typhoid complications, TB and cardiac arrest, doctors said.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
Cancer History In Family? What You Can Do To Reduce Risk
When multiple members of a family have had cancer especially at young ages or at the same site, it can signal inherited risk factors.
-
2026 Needs A National Obesity Strategy: Doctor Explains Why Weight Is Now A Public Health Emergency
The rising obesity trend is seriously worrying and requires urgent, dedicated and consistent intervention on both micro and macro scales.
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Doctor Shares The Top Healthcare Challenges India Must Solve In 2026, Before The Costs Become Unmanageable
Dr Sabine Kapasi explains how India is entering a year where further delay in healthcare reforms and advances will widen existing gaps in care.
-
Ozempic, Type 2 Diabetes, Weight Loss Drug Launched In India. Check Price
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming diabetes and obesity market expected to power industry growth this decade.
-
Study Finds Low Blood Choline As Possible Factor In Obesity-Related Alzheimer's Risk
A study links low blood choline levels in obese young adults to liver dysfunction, insulin resistance, and markers associated with increased Alzheimer's risk.
-
One In Four Indian Adults Obese, Claims New Report
Quoting the National Family Health Survey 2019-21, the study says that in Delhi, 41 per cent of women are obese compared to 12 per cent in Meghalaya.
-
Ultra-Processed Food Sales Surge In India, Causing Obesity And Diabetes Crisis: Lancet Study
India is seeing the fastest ultra-processed food (UPF) sales growth, which is surging obesity and diabetes cases, according to The Lancet.
-
"Reduce Edible Oil Consumption By 10 Per Cent": PM Narendra Modi's Message During Chat With Women's World Cup Winners
PM Narendra Modi advised people to reduce their consumption of edible oil at home as part of a larger national health initiative.
-
Opinion | The Rich Get Fit, And Poor Get 'Lectures' - That's India's Ozempic Problem
Ozempic has arrived in India - and so has the moral panic around it.
